These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 35364298)
1. The Influence of Select Medications on Prospective Hemorrhage Risk in Patients with Spinal or Cerebral Cavernous Malformations. Previch L; Lanzino G; Brown RD; Flemming KD World Neurosurg; 2022 Jul; 163():e678-e683. PubMed ID: 35364298 [TBL] [Abstract][Full Text] [Related]
2. Predictors of Initial Presentation with Hemorrhage in Patients with Cavernous Malformations. Flemming KD; Kumar S; Brown RD; Lanzino G World Neurosurg; 2020 Jan; 133():e767-e773. PubMed ID: 31605843 [TBL] [Abstract][Full Text] [Related]
3. Cavernous Malformation Hemorrhagic Presentation at Diagnosis Associated with Low 25-Hydroxy-Vitamin D Level. Flemming KD; Kumar S; Brown RD; Singh RJ; Whitehead K; McCreath L; Lanzino G Cerebrovasc Dis; 2020; 49(2):216-222. PubMed ID: 32348981 [TBL] [Abstract][Full Text] [Related]
4. Association Between Beta-Blocker or Statin Drug Use and the Risk of Hemorrhage From Cerebral Cavernous Malformations. Zuurbier SM; Hickman CR; Rinkel LA; Berg R; Sure U; Al-Shahi Salman R; Stroke; 2022 Aug; 53(8):2521-2527. PubMed ID: 35410492 [TBL] [Abstract][Full Text] [Related]
5. Clinical presentation, hemorrhage risk, and outcome in patients with familial cavernous malformations: a pragmatic prospective analysis of 75 patients. Alalfi MO; Lanzino G; Flemming KD J Neurosurg; 2023 Oct; 139(4):1018-1024. PubMed ID: 36933254 [TBL] [Abstract][Full Text] [Related]
6. The Influence of Physical Activity on Cavernous Malformation Hemorrhage. Joseph NK; Kumar S; Lanzino G; Flemming KD J Stroke Cerebrovasc Dis; 2020 Apr; 29(4):104629. PubMed ID: 32147026 [TBL] [Abstract][Full Text] [Related]
7. Influence of Pregnancy on Hemorrhage Risk in Women With Cerebral and Spinal Cavernous Malformations. Joseph NK; Kumar S; Brown RD; Lanzino G; Flemming KD Stroke; 2021 Jan; 52(2):434-441. PubMed ID: 33493052 [TBL] [Abstract][Full Text] [Related]
8. Use of antithrombotic agents in patients with intracerebral cavernous malformations. Flemming KD; Link MJ; Christianson TJ; Brown RD J Neurosurg; 2013 Jan; 118(1):43-6. PubMed ID: 22998055 [TBL] [Abstract][Full Text] [Related]
10. Are there differences in clinical presentation, radiologic findings, and outcomes in female patients with cavernous malformation? Flemming KD; Lanzino G Acta Neurochir (Wien); 2023 Jul; 165(7):1855-1861. PubMed ID: 37306819 [TBL] [Abstract][Full Text] [Related]
11. Impact of Long-Term Antithrombotic and Statin Therapy on the Clinical Outcome in Patients with Cavernous Malformations of the Central Nervous System: A Single-Center Case Series of 428 Patients. Wildi S; Nager S; Akeret K; Özkaratufan S; Krayenbühl N; Bozinov O; Regli L; Velz J Cerebrovasc Dis; 2023; 52(6):634-642. PubMed ID: 36944322 [TBL] [Abstract][Full Text] [Related]
12. Antithrombotic Therapy in Cerebral Cavernous Malformations: A Systematic Review, Meta-Analysis, and Network Meta-Analysis. Musmar B; Salim H; Abdelgadir J; Spellicy S; Adeeb N; Zomorodi A; Friedman A; Awad I; Jabbour PM; Hasan DM J Am Heart Assoc; 2024 Mar; 13(6):e032910. PubMed ID: 38471833 [TBL] [Abstract][Full Text] [Related]
13. Bleeding Risk of Cerebral Cavernous Malformations in Patients on Statin and Antiplatelet Medication: A Cohort Study. Marques LL; Jaeggi C; Branca M; Raabe A; Bervini D; Goldberg J Neurosurgery; 2023 Sep; 93(3):699-705. PubMed ID: 36999926 [TBL] [Abstract][Full Text] [Related]
14. Hemorrhage risks and functional outcomes of untreated brainstem cavernous malformations. Li D; Hao SY; Jia GJ; Wu Z; Zhang LW; Zhang JT J Neurosurg; 2014 Jul; 121(1):32-41. PubMed ID: 24785325 [TBL] [Abstract][Full Text] [Related]
15. Clinical course of untreated thalamic cavernous malformations: hemorrhage risk and neurological outcomes. Tian KB; Zheng JJ; Ma JP; Hao SY; Wang L; Zhang LW; Wu Z; Zhang JT; Li D J Neurosurg; 2017 Sep; 127(3):480-491. PubMed ID: 27834594 [TBL] [Abstract][Full Text] [Related]
16. Female Hormone Therapy and Risk of Intracranial Hemorrhage From Cerebral Cavernous Malformations: A Multicenter Observational Cohort Study. Zuurbier SM; Santos AN; Flemming KD; Schmidt B; Jabbarli R; Lanzino G; Sure U; Dammann P Neurology; 2023 Apr; 100(16):e1673-e1679. PubMed ID: 36754635 [TBL] [Abstract][Full Text] [Related]
17. Five-year symptomatic hemorrhage risk of untreated brainstem cavernous malformations in a prospective cohort. Kong L; Ma XJ; Xu XY; Liu PP; Wu ZY; Zhang LW; Zhang JT; Wu Z; Wang L; Li D Neurosurg Rev; 2022 Aug; 45(4):2961-2973. PubMed ID: 35633420 [TBL] [Abstract][Full Text] [Related]
18. Symptomatic Cavernous Malformation Presenting with Seizure without Hemorrhage: Analysis of Factors Influencing Clinical Presentation. Agosti E; Flemming KD; Lanzino G World Neurosurg; 2019 Sep; 129():e387-e392. PubMed ID: 31132505 [TBL] [Abstract][Full Text] [Related]
19. Hemorrhage from cerebral cavernous malformations: a systematic pooled analysis. Gross BA; Du R J Neurosurg; 2017 Apr; 126(4):1079-1087. PubMed ID: 27203143 [TBL] [Abstract][Full Text] [Related]